Home › Funds › ARS Wealth Advisors Group, LLC › JNJ

ARS Wealth Advisors Group, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

ARS Wealth Advisors Group, LLC reported holding 119,581 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$31.7M, representing 2.30% of its reported portfolio and ranking #14 among its reported holdings. ARS Wealth Advisors Group, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)119.58K sh
Reported value held$31.66M
Portfolio Weight2.30%
First reportedQ3 2023
Last changeReduce
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How ARS Wealth Advisors Group, LLC's JNJ position evolved

ARS Wealth Advisors Group, LLC first disclosed a stake in JNJ in Q3 2023 at 62,827 shares (US$9.8M). The position peaked in Q3 2026 at 119,581 shares, worth US$31.7M. Across 13 filings, ARS Wealth Advisors Group, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 119,581 shares valued at US$31.7M — a reduction of -1,525 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2023 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 62.83K $9.79M New
Q4 2023 98.17K $15.39M Add
Q1 2024 107.48K $17.00M Add
Q2 2024 114.17K $16.69M Add
Q3 2024 115.41K $18.70M Add
Q4 2024 116.91K $16.91M Add
Q1 2025 119.02K $19.74M Add
Q2 2025 123.37K $18.84M Add
Q3 2025 124.62K $23.11M Add
Q4 2025 125.24K $25.92M Hold
Q1 2026 123.18K $30.11M Reduce
Q2 2026 121.11K $30.76M Reduce
Q3 2026 119.58K $31.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ARS Wealth Advisors Group, LLC held JNJ?

ARS Wealth Advisors Group, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARS Wealth Advisors Group, LLC's current position in JNJ?

As of Q3 2026, ARS Wealth Advisors Group, LLC holds 119.58K shares of JNJ (JOHNSON & JOHNSON), valued at $31.66M, representing 2.30% of its reported portfolio and ranking #14.

Has ARS Wealth Advisors Group, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ARS Wealth Advisors Group, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 119.58K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.